1-4 of 4
David Kirn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses

Yaohe Wang, Stephen Thorne, Joseph Hannock, Jennelle Francis, Tina Au, Tony Reid, Nick Lemoine, David Kirn, Gunnel Halldén
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 351–360.
https://doi.org/10.1158/1078-0432.351.11.1
Published: 21 January 2005
View article titled, A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses
Open the PDF for A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses in another window
Journal Articles

The dl1520 Virus Is Found Preferentially in Tumor Tissue after Direct Intratumoral Injection in Oral Carcinoma

Stephen Morley, Gordon MacDonald, David Kirn, Stan Kaye, Robert Brown, David Soutar
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4357–4362.
https://doi.org/10.1158/1078-0432.CCR-03-0443
Published: 06 July 2004
View article titled, The dl1520 Virus Is Found Preferentially in Tumor Tissue after Direct Intratumoral Injection in Oral Carcinoma
Open the PDF for The dl1520 Virus Is Found Preferentially in Tumor Tissue after Direct Intratumoral Injection in Oral Carcinoma in another window
Journal Articles

Efficacy with a Replication-selective Adenovirus Plus Cisplatin-based Chemotherapy: Dependence on Sequencing but not p53 Functional Status or Route of Administration

Carla Heise, Marilyn Lemmon, David Kirn
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4908–4914.
Published: 01 December 2000
View article titled, Efficacy with a Replication-selective Adenovirus Plus Cisplatin-based Chemotherapy: Dependence on Sequencing but not p53 Functional Status or Route of Administration
Open the PDF for Efficacy with a Replication-selective Adenovirus Plus Cisplatin-based Chemotherapy: Dependence on Sequencing but not p53 Functional Status or Route of Administration in another window
Journal Articles

A Phase I Study of Onyx-015, an E1B Attenuated Adenovirus, Administered Intratumorally to Patients with Recurrent Head and Neck Cancer

Ian Ganly, David Kirn, Susan G. Eckhardt, Gail I. Rodriguez, David S. Soutar, Randol Otto, Andrew G. Robertson, Oirhigh Park, Mark L. Gulley, Carla Heise, Daniel D. Von Hoff, Stanley B. Kaye
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (3): 798–806.
Published: 01 March 2000
View article titled, A Phase I Study of Onyx-015, an E1B Attenuated Adenovirus, Administered Intratumorally to Patients with Recurrent Head and Neck Cancer
Open the PDF for A Phase I Study of Onyx-015, an E1B Attenuated Adenovirus, Administered Intratumorally to Patients with Recurrent Head and Neck Cancer in another window